Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis

BACKGROUND: Poly-(ADP-ribose)-polymerase (PARP) inhibitors have shown to be effective as maintenance treatment in patients with advanced ovarian cancer. Although most ovarian cancers develop after age 65, older patients are often under-represented in clinical trials. OBJECTIVE: To assess the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiorano, Brigida Anna, Maiorano, Mauro Francesco Pio, Lorusso, Domenica, Di Maio, Massimo, Maiello, Evaristo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664098/
https://www.ncbi.nlm.nih.gov/pubmed/36229080
http://dx.doi.org/10.1136/ijgc-2022-003614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664098/
https://www.ncbi.nlm.nih.gov/pubmed/36229080
http://dx.doi.org/10.1136/ijgc-2022-003614

Ejemplares similares